Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 1
2006 1
2007 6
2008 1
2009 2
2010 6
2011 6
2012 6
2013 2
2014 1
2015 4
2016 6
2017 11
2018 7
2019 7
2020 7
2021 9
2022 16
2023 20
2024 30
2025 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: in the last 1 year. Clear all
Page 1
Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease.
O'Sullivan J, Patel S, Leventhal GE, Fitzgerald RS, Laserna-Mendieta EJ, Huseyin CE, Konstantinidou N, Rutherford E, Lavelle A, Dabbagh K, DeSantis TZ, Shanahan F, Temko A, Iwai S, Claesson MJ. O'Sullivan J, et al. Gut Microbes. 2025 Dec;17(1):2450207. doi: 10.1080/19490976.2025.2450207. Epub 2025 Jan 15. Gut Microbes. 2025. PMID: 39812341 Free PMC article.
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD Diagnostics.
Mookhoek A, Sinonque P, Allocca M, Carter D, Ensari A, Iacucci M, Kopylov U, Verstockt B, Baumgart DC, Noor NM, El-Hussuna A, Sahnan K, Marigorta UM, Noviello D, Bossuyt P, Pellino G, Soriano A, de Laffolie J, Daperno M, Raine T, Cleynen I, Sebastian S. Mookhoek A, et al. J Crohns Colitis. 2025 Aug 12:jjaf133. doi: 10.1093/ecco-jcc/jjaf133. Online ahead of print. J Crohns Colitis. 2025. PMID: 40796218
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in IBD: Regulatory and Methodological Considerations.
Noor NM, Daperno M, de Laffolie J, Mookhoek A, Sinonquel P, Kopylov U, Verstockt B, El-Hussuna A, Sahnan K, Allocca M, Bossuyt P, Carter D, Ensari A, Iacucci M, Marigorta UM, Noviello D, Pellino G, Soriano A, Cleynen I, Raine T, Sebastian S, Baumgart DC. Noor NM, et al. J Crohns Colitis. 2025 Aug 12:jjaf136. doi: 10.1093/ecco-jcc/jjaf136. Online ahead of print. J Crohns Colitis. 2025. PMID: 40796209
Advancing Inflammatory Bowel Disease-Driven Colorectal Cancer Management: Molecular Insights and Endoscopic Breakthroughs Towards Precision Medicine.
Iacucci M, Nardone OM, Ditonno I, Capobianco I, Pugliano CL, Maeda Y, Majumder S, Zammarchi I, Santacroce G, Ghosh S. Iacucci M, et al. Clin Gastroenterol Hepatol. 2025 Jul 22:S1542-3565(25)00616-0. doi: 10.1016/j.cgh.2025.06.035. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40706730 Free article. Review.
Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study.
Jairath V, D'Haens G, Sands BE, Travis S, Chaparro M, Peyrin-Biroulet L, Chen MH, Dubinsky M, Ferrante M, Schreiber S, McGinnis K, Vadhariya A, Appelmans S, Lin Z, Yu G, Protic M, Moses R, Ghosh S. Jairath V, et al. Clin Gastroenterol Hepatol. 2025 Jul 14:S1542-3565(25)00581-6. doi: 10.1016/j.cgh.2025.07.003. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 40669578 Free article.
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2.
Yanai H, Feakins R, Allocca M, Burisch J, Ellul P, Iacucci M, Maaser C, Zilli A, Zidar N, Wilkens R, Verstockt B, Vavricka S, Uzzan M, Stoker J, Scharitzer M, Rubin D, Rosini F, Rimola J, van Rheenen P, Borralho Nunes P, Novak K, Noor NM, Nardone OM, Lu C, Kopylov U, Katsanos K, de Kock I, Kellar A, Karmiris K, Maconi G, Furfaro F, Flanagan E, Driessen A, Chavannes M, Bettenworth D, Ben-Horin S, Bhatnagar G, Baldin P, Kucharzik T, Taylor S. Yanai H, et al. J Crohns Colitis. 2025 Jul 3;19(7):jjaf107. doi: 10.1093/ecco-jcc/jjaf107. J Crohns Colitis. 2025. PMID: 40742985 No abstract available.
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1.
Kucharzik T, Taylor S, Allocca M, Burisch J, Ellul P, Iacucci M, Maaser C, Baldin P, Bhatnagar G, Ben-Horin S, Bettenworth D, Chavannes M, Driessen A, Flanagan E, Furfaro F, Maconi G, Karmiris K, Kellar A, De Kock I, Katsanos K, Kopylov U, Lu C, Nardone OM, Noor NM, Novak K, Borralho Nunes P, van Rheenen P, Rimola J, Rosini F, Rubin D, Scharitzer M, Stoker J, Uzzan M, Vavricka S, Verstockt B, Wilkens R, Zidar N, Zilli A, Yanai H, Feakins R. Kucharzik T, et al. J Crohns Colitis. 2025 Jul 3;19(7):jjaf106. doi: 10.1093/ecco-jcc/jjaf106. J Crohns Colitis. 2025. PMID: 40741688
Gaps between European Crohn's and Colitis Organisation quality standards of care and the real world on diagnosis and monitoring inflammatory bowel disease across Europe: results from the E-QUALITY survey.
Fiorino G, Fidalgo C, Adamina M, Barreiro-de Acosta M, Ali MP, Bortlik M, Burisch J, Dignass A, Drobne D, Faiz O, Ferrante M, Fierens L, Godny L, Gojdicova A, Iacucci M, Jӓghult S, Karmiris K, Kirchgesner J, Restellini S, Rosini F, Shouval D, Yanai H, Zagórowicz E, Walsh A. Fiorino G, et al. J Crohns Colitis. 2025 Jul 3;19(7):jjaf105. doi: 10.1093/ecco-jcc/jjaf105. J Crohns Colitis. 2025. PMID: 40576379
Gaps between European Crohn's Colitis Organisation quality standards of care and the real world on structure of IBD units across Europe: results from E-QUALITY survey.
Fiorino G, Walsh A, Adamina M, Barreiro-de Acosta M, Ali MP, Bortlik M, Burisch J, Dignass A, Drobne D, Faiz O, Ferrante M, Fierens L, Godny L, Gojdicova A, Iacucci M, Jӓghult S, Karmiris K, Kirchgesner J, Restellini S, Rosini F, Shouval D, Van Deen W, Yanai H, Zagórowicz E, Fidalgo C. Fiorino G, et al. J Crohns Colitis. 2025 Jul 3;19(7):jjaf094. doi: 10.1093/ecco-jcc/jjaf094. J Crohns Colitis. 2025. PMID: 40512137
Understanding the therapeutic toolkit for inflammatory bowel disease.
Vieujean S, Jairath V, Peyrin-Biroulet L, Dubinsky M, Iacucci M, Magro F, Danese S. Vieujean S, et al. Nat Rev Gastroenterol Hepatol. 2025 Jun;22(6):371-394. doi: 10.1038/s41575-024-01035-7. Epub 2025 Jan 31. Nat Rev Gastroenterol Hepatol. 2025. PMID: 39891014 Review.
British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease.
East JE, Gordon M, Nigam GB, Sinopoulou V, Bateman AC, Din S, Iacucci M, Kabir M, Lamb CA, Wilson A, Al Bakir I, Dhar A, Dolwani S, Faiz O, Hart A, Hayee B, Healey C, Leedham SJ, Novelli MR, Raine T, Rutter MD, Shepherd NA, Subramanian V, Vance M, Wakeman R, White L, Trudgill NJ, Morris AJ. East JE, et al. Gut. 2025 Apr 30:gutjnl-2025-335023. doi: 10.1136/gutjnl-2025-335023. Online ahead of print. Gut. 2025. PMID: 40306978 Free article.
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.